Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1225-1230

  Zhao, Yunfeng ^a   Liu, Jianfeng ^a   McMartin, Kenneth E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Differentiation; Melanoma; NADPH oxidase; Oxidative stress

Indexed keywords

DIPHENYLIODONIUM SALT; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P47; PROTEIN P53; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; MELANIN; MITF PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GROWTH INHIBITION; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; ENZYME ACTIVATION; EXPERIMENTAL MELANOMA; GENE EXPRESSION REGULATION; METABOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; MELANINS; MELANOMA, EXPERIMENTAL; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 47549088305     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1225     Document Type: Article

References (24)

1. Oberley LW: Mechanism of the tumor suppressive effect of MnSOD overexpression (Review). Biomed Pharmacother 59: 143-148, 2005.
2. Hoeng MT and Eichenfield LF: The rising incidence of melanoma in children and adolescents. Dermatol Nurs 12: 188-193, 2000.
3. Brar SS, Kennedy TP, Sturrock AB, et al: An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282: C1212-C1224, 2002.
4. Zhao Y, Chaiswing L, Bakthavatchalu V, et al: Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogenesis 27: 1692-1698, 2006.
5. Cui XL and Douglas JG: Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 94: 3771-3776, 1997.
6. Hakozaki T, Minwalla L, Zhuang J, et al: The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 147: 20-31, 2002.
7. St. Clair DK, Oberley TD, Muse KE, et al: Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic Biol Med 16: 275-282, 1994.
8. Zhao Y, Kiningham KK, Lin SM et al: Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apotosis and promotes a differentiation program upon treatment with 5-azacytidine: involvement of MAPK and NFkappaB pathways. Antioxid Redox Signal 3: 375-386, 2001.
9. Lahn MM and Sundell KL: The role of protein kinase C-alpha (PKC-alpha) in melanoma (Review). Melanoma Res 14: 85-89, 2004.
10. Smalley KS: A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? (Review) Int J Cancer 104: 527-532, 2003.
11. Pollock PM, Walker GJ, Glendening JM, et al: PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines. Melanoma Res 12: 565-575, 2002.
12. Rauth S, Kichina J and Green A: Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. Br J Cancer 75: 1559-1566, 1997.
13. St. Clair DK, Zhao Y, Chaiswing L, et al: Modulation of skin tumorigenesis by SOD (Review). Biomed Pharmacother 59: 209-214, 2005.
14. Smith J, Ladi E, Mayer-Proschel M, et al: Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci USA 97: 10032-10037, 2000.
15. Kinnula VL and Crapo JD: Superoxide dismutases in malignant cells and human tumors (Review). Free Radic Biol Med 36: 718-744, 2004.
16. Piao YJ, Seo YH, Hong F, et al: Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Radic Biol Med 38: 989-1001, 2005.
17. Sturrock A, Cahill B, Norman K, et al: Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290: L661-L673, 2006.
18. Leszczyniecka M, Roberts T, Dent P, et al: Differentiation therapy of human cancer: basic science and clinical applications (Review). Pharmacol Ther 90: 105-156, 2001.
19. Miller AJ and Mihm Jr MC: Melanoma. N Engl J Med 355: 51-65, 2006.
20. Goding CR: Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 14: 1712-1728, 2000.
21. Wu M, Hemesath TJ, Takemoto CM, et al: c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14: 301-312, 2000.
22. Yamada KM and Araki M: Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis (Review). J Cell Sci 114: 2375-2382, 2001.
23. Ilmonen S, Hernberg M, Pyrhonen S, et al: Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma. Melanoma Res 15: 375-381, 2005.
24. Melnikova VO, Bolshakov SV, Walker C, et al: Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene 23: 2347-2356, 2004.